Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['text,(-texte),(-texti)', 'rcc,(-irccs),(-srcc),(-urcc)', 'pembro']
 the final point is a good one. adjuvant pembro is an important addition to the rcc armamentarium, but it s not a slam dunk given the broader context. we will treat a lot who didn t benefit from it.
Cancer Immunology • Developmental Therapeutics • Phase I trials • Genitourinary Oncology • Tweets are my own & not medical advice